Lindbrook Capital’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.89K Sell
326
-747
-70% -$12.5K ﹤0.01% 1962
2024
Q4
$18.6K Buy
1,073
+40
+4% +$772 ﹤0.01% 1321
2024
Q3
$19.1K Sell
1,033
-741
-42% -$14.9K ﹤0.01% 1324
2024
Q2
$36K Sell
1,774
-1,939
-52% -$34.3K ﹤0.01% 933
2024
Q1
$63.4K Buy
3,713
+612
+20% +$9.63K 0.01% 688
2023
Q4
$54.8K Sell
3,101
-79
-2% -$1.59K 0.01% 719
2023
Q3
$76.4K Buy
3,180
+58
+2% +$1.42K 0.01% 541
2023
Q2
$72.6K Hold
3,122
0.01% 583
2023
Q1
$68.8K Buy
3,122
+66
+2% +$1.54K 0.01% 586
2022
Q4
$61.9K Buy
3,056
+256
+9% +$4.96K 0.01% 614
2022
Q3
$38K Buy
2,800
+51
+2% +$859 0.01% 748
2022
Q2
$54K Buy
2,749
+11
+0.4% +$292 0.01% 625
2022
Q1
$87K Hold
2,738
0.01% 501
2021
Q4
$61K Hold
2,738
0.01% 652
2021
Q3
$76K Hold
2,738
0.02% 328
2021
Q2
$107K Hold
2,738
0.02% 279
2021
Q1
$79K Hold
2,738
0.02% 318
2020
Q4
$73K Hold
2,738
0.02% 305
2020
Q3
$42K Hold
2,738
0.01% 397
2020
Q2
$56K Buy
2,738
+2,393
+694% +$42.9K 0.02% 337
2020
Q1
$4K Buy
345
+303
+721% +$8.47K ﹤0.01% 1066
2019
Q4
$2K Buy
+42
New +$1.89K ﹤0.01% 1272

Other funds holding CLB

Lindbrook Capital's CLB Position: Q1 2025 in Review

Lindbrook Capital reduced its Core Laboratories (CLB) stake by 70% in Q1 2025, selling an estimated $12.5K and leaving 326 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Lindbrook Capital first reported a position in CLB in Q4 2019 and has held it in 22 quarters since. The position peaked at $107K in Q2 2021. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Lindbrook Capital held 326 shares of Core Laboratories worth $4.89K as of Q1 2025.
  • Lindbrook Capital sold 747 Core Laboratories shares in Q1 2025, an estimated $12.5K.
  • Core Laboratories made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1962 holding.
  • Lindbrook Capital first reported a position in Core Laboratories in Q4 2019 and has held it in 22 quarters since.
  • Lindbrook Capital's Core Laboratories position peaked at $107K in Q2 2021.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.